References
- Taylor A T. Catatonia: a review of a behavioural neurological syndrome. Neuropsychiatry, Neuropsychology, and Behavioural Neurology 1990; 3: 48–72
- Regestein Q R, Alpert J S, Reich P. Sudden catatonic stupor with disastrous outcome. Journal of the American Medical Association 1977; 238: 618–620
- Mahendra B. Editorial: Where have all the catatonics gone?. Psychological Medicine 1981; 11: 669–671
- Abrams R, Taylor M A. Catatonia: Prediction of response to somatic treatments. American Journal of Psychiatry 1977; 134: 78–80
- Rosebush P I, Hildebrand A M, Furlong B G, et al. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. Journal of Clinical Psychiatry 1990; 51: 357–362
- McEvoy J P, Lohr J B. Diazepam for catatonia. American Journal of Psychiatry 1984; 141: 284–285
- Greenfeld D, Conrad C, Kincare P, Bowers M B. Treatment of catatonia with low-dose lorazepam. American Journal of Psychiatry 1987; 144: 1224–1225
- Gelenberg A J, Mandel M R. Catatonic reaction to high-potency neuroleptic drugs. Archives of General Psychiatry 1977; 34: 947–950
- Fink M, Taylor M A. Catatonia: a separate category in DSM-IV. Integrative Psychiatry 1991; 7: 2–10
- Bowlby J. Attachment (Vol. 1). Pelican, MiddlesexUK 1971
- Meares R. The persecutory therapist in the pursuit of intimacy. Nelson, Melbourne, Vic 1977
- Rogeness G A, Javors M A, Pliszka S R. Neurochemistry and child and adolescent psychiatry. Journal of the American Academy of Child and Adolescent Psychiatry 1992; 31: 765–781
- Salkovskis P M, Atha C, Storer D. Cognitive behavioural problem solving in the treatment of patients who repeatedly attempt suicide: a controlled trial. British Journal of Psychiatry 1990; 157: 871–876
- House A, Owens D, Storer D. Psycho-social intervention following attempted suicide: is there a case for better services?. International Review of Psychiatry 1992; 4: 15–22
- Gunnell D, Frankel S. Prevention of suicide: aspirations and evidence. British Medical Journal 1994; 308: 1227–1233
- Lipinski J F, Mallya G, Zimmerman P, Pope H G. Fluoxetine-induced akathisia: Clinical and theoretical implications. Journal of Clinical Psychiatry 1989; 50: 339–342
- Meltzer H Y, Matsubara S, Lee J C. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin-2 pKi values. Journal of Pharmacology and Experimental Therapeutics 1989; 251: 238–246
- Bernick C. Methysergide-induced akathisia. Clinical Neuropharmacology 1988; 11: 87–89
- Kramer M S, DiJohnson C, Davis P, et al. L-tryptophan in neuroleptic-induced akathisia. Biological Psychiatry 1990; 27: 671–672
- Ugedo L, Grenhoff J, Svensson T H. Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition. Psychopharmacology 1989; 98: 45–50
- Blandina P, Goldfarb J, Green J P. Activation of a 5-HT3 receptor releases dopamine from rat striatal slice. European Journal of Pharmacology 1988; 155: 349–350
- Waddington J L. Schizophrenia, affective psychoses and other disorders treated with neuroleptic drugs: The enigma of tardive dyskinesia, its neurobiological determinants and the conflict of paradigms. Intenational Review of Neuroscience 1989; 31: 297–353
- Casey D E. Spontaneous and tardive dyskinesia: Clinical and laboratory studies. Journal of Clinical Psychiatry 1985; 46: 42–47
- Ayd F J. A survey of drug-induced extrapyramidal reactions. Journal of the American Medical Association 1961; 175: 1054–1060
- Sachdev P. Depression-dependent exacerbation of tardive dyskinesia. British Journal of Psychiatry 1989; 155: 253–255
- Reynolds G P, Brown J E, McCall J C, MacKay A VP. Dopamine receptor abnormalities in the striatum and pallidum in tardive dyskinesia: a post morlem study. Journal of Neural Transmission 1992; 87: 225–230
- Lewander T, Westerbergh S-E, Morrison D. Clinical profile of remoxipride - a combined analysis of a comparative double blind, multicentre trial programme. Acta Psychiatrica Scandinavica 1990; 82: 92–98
- Arya D K, Szabadie E. Dyskinesia associated with fluvoxamine. (Letter) Journal of Clinical Psychopharmacology 1993; 13: 365–366
- Mander A G, McCausland B, Workman B, Flamer H, Christophidis N. Fluoxetine induced dyskinesia. Australian and New Zealand Journal of Psychiatry 1994; 28: 328–330
- Hunter E. Aboriginal suicides in custody: A view from the Kimberley. Australian and New Zealand Journal of Psychiatry 1988; 22: 273–282
- Hunter E. On Gordian knots and nooses: Aboriginal suicide in the Kimberley. Australian and New Zealand Journal of Psychiatry 1988; 22: 264–271
- Meggitt M J. Desert people: A study of the Walpiri Aborigines of Central Australia. Angus and Robertson, Sydney 1962
- Elkin A P. The Australian Aborigines: How to understand them. Angus and Robertson, Sydney 1945
- Hart C WM, Pilling A R, Goodale J C. The Tiwi of North Australia, 3rd edition. Holt, Rinehart and Winston, New York 1988
- Eastwell H. The low risk of suicide amongst the Yolngu of the Northern Territory: the traditional Aboriginal pattern. Medical Journal of Australia 1988; 148: 338–340
- Jones I, de L Home D J. Diagnosis of psychiatric illness among tribal Aborigines. Medical Journal of Australia 1972; 1: 345–349